1200024000132002640013200264001440028800
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)

1200024000132002640013200264001440028800
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)
Application to the diagnosis and prognostic stratification of multiple myeloma. Two fusion genes, [MAF/IGH]/[FGFR3/IGH], were introduced on the basis of [D13S319/p53]/1q21, and if the IGH translocation was positive, the two translocations, t(14;16) [MAF/IGH] and t(4;14) [FGFR3/IGH], were detected together. These two translocations are associated with poor prognosis; and t(4;14) [FGFR3/IGH] is not detected by conventional karyotyping. This product combines diagnostic and prognostic stratification in a single product that includes a diagnostic package for primary screening and, most importantly, a fusion probe for prognostic stratification.